Keyphrases
Fontan Patients
100%
Fontan
42%
Cyanotic Congenital Heart Disease
40%
Quality of Life
34%
Exercise Capacity
31%
Congenital Heart Disease
30%
Univentricular Heart
30%
Fontan Procedure
27%
Exercise Intolerance
22%
Adult Congenital Heart Disease
20%
Total Cavopulmonary Connection
20%
Asymptomatic children
20%
Bosentan
20%
Ventricular Septal Defect
19%
Hematocrit
18%
Pulmonary Function Test
17%
Sudden Cardiac Death
16%
Heart Failure Patients
16%
Arrhythmia
15%
Ten Year Period
15%
Population-based
13%
Single Ventricle
13%
Endothelin Receptor Antagonist
13%
Denmark
13%
Adult Patients
13%
Thromboelastography
12%
Etiology
12%
Fontan Circulation
12%
Cardiovascular Complications
11%
Pulmonary Diffusing Capacity
11%
Older Patients
11%
VO2peak
11%
Maximal Oxygen Uptake
11%
Diffusing Capacity
11%
Hemostasis
11%
Stroke Volume Index
10%
Keys to Success
10%
Health-related Quality of Life
10%
Systemic Right Ventricle
10%
Somatic Growth
10%
Placebo-controlled Double-blind Study
10%
Consumption Studies
10%
Out-of-hospital Cardiac Arrest
10%
Time Trends
10%
Pulmonary Thrombosis
10%
Single Ventricle Physiology
10%
Physical Activity
10%
Comorbidity
10%
Subclinical Hypothyroidism
10%
Lifetime Risk
10%
Medicine and Dentistry
Persistent Truncus Arteriosus
40%
Heart Single Ventricle
34%
Quality of Life
34%
Cyanotic Heart Defect
30%
Prevalence
20%
Exercise Intolerance
20%
Ventricular Septal Defect
19%
Sudden Cardiac Death
16%
Lung Function Test
16%
Wolff-Parkinson-White Syndrome
15%
Lung Diffusion Capacity
13%
Hemodynamic
13%
Exercise
12%
Cardiac Dysrhythmia
12%
Heart Surgery
11%
Cardiovascular Disease
11%
Stroke Volume
11%
Hematocrit
11%
Childbirth
11%
Body Growth
10%
Risk Stratification
10%
Tetralogy of Fallot
10%
Great Arteries
10%
Adult Congenital Heart Disease
10%
Cavopulmonary Connection
10%
Heart Arrest
10%
Out of Hospital Cardiac Arrest
10%
Adolescent
10%
Cognition
10%
Subclinical Hypothyroidism
10%
Physical Activity
10%
Liver Disease
10%
Lifespan
10%
Right Ventricle
10%
Blood Stasis
10%
Left Ventricle
10%
Patient-Reported Outcome
10%
Lung Development
10%
Diffusing Capacity
10%
Cohort Analysis
10%
Thrombosis
10%
Anticoagulation
10%
Salmonella
10%
Aortic Valve
10%
Endocarditis
10%
Fontan Procedure
9%
Hemostat
9%
Atrial Septal Defect
8%
Electrocardiogram
8%
Atrial Fibrillation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cyanotic Heart Disease
40%
Prevalence
36%
Heart Single Ventricle
33%
Thromboembolism
28%
Congenital Heart Disease
20%
Bosentan
20%
Hemostatic Agent
16%
Heart Arrhythmia
15%
Endothelin Receptor Antagonist
15%
Blood Stasis
13%
Fibrinogen
12%
Health Survey
10%
Comorbidity
10%
Thrombosis
10%
Placebo
10%
Subclinical Hypothyroidism
10%
Liver Disease
10%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
10%
Endocarditis
10%
Salmonella
10%
Endothelin 1
8%
Hemoptysis
7%
Protein Losing Gastroenteropathy
5%
Life Expectancy
5%
